Abstract
1-Methyl, 4-phenyl,l,2,5,6,tetrahydropyridine (MPTP) is a dopaminergic toxin which produces Parkinson’s disease-like symptoms in primates and dopaminergic cell loss in mice. MPTP is bioactivated through monoamine oxidase to MPP+ and detoxified by cytochrome P450 to nor-MPTP. We have examined metabolisms of MPTP to nor-MPTP by mouse brain microsomes and compared it with corresponding activity in liver. In brain, but not in liver, this biotransformation was completely abolished by quinidine, an inhibitor of P4502D. Northern blotting experiments demonstrated constitutive expression of cytochrome P4502D in mouse brain. A fluorescencein situ hybridization study of mouse brain showed presence of P4502D mRNA predominantly in neuronal cells within the cortex, hippocampus, thalamus, Purkinje and granule cell layers of the cerebellum and in the reticular neurons of midbrain. Striatal neurons were sparsely stained indicating a relative paucity of expression. These studies demonstrate for the first time that detoxification of MPTP to nor-MPTP occurs in mouse brain through cytochrome P4502D which is primarily localized in neuronal cells. Cytochrome P4502D6 is known to exhibit genetic polymorphism in humans, and a defect in this isoform could potentially lead to decreased detoxification of neurotoxins in certain neuronal sub-population, which in turn may have implications in pathogenesis of Parkinson’s disease.
Similar content being viewed by others
Abbreviations
- MPTP:
-
Cytochrome P450 — P450
- MPTP:
-
1-methyl,4-phenyl,l,2,5,6,tetrahydropyridine
- MPDP+ :
-
l-methyl,4-phenyl 4, 5 dihydropyridinium ion
- MPP+ :
-
1-methyl, 4-phenyl pyridiniumion
References
Anandatheerthavarada, H.K., Shankar, S.K. and Ravin-dranath V., (1990) Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms.Brain Res 17;536(l-2): pp. 339–43.
Bradford, M. M., (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding.Anal. Biochem. 72, pp. 248–254.
Bhagwat, S.V., Boyd, M. R. and Ravindranath V., (1995) Brain mitochondrial cytochromes P-450: Xenobiotic metabolism, presence of multiple forms and their selective inducibility.Arch. Biochem. Biophys. 320: pp. 73–83.
Burns, R.S., Chuang, C.C., Markey, S.P., Elbert, M.H., Jacob-witz, D.M. and Kopin I.J., (1983) A primate model for Parkinsonism: selective destruction of dopaminergic neurons in pars compacta of substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine.Proc. Natl. Acad. Sci. U.S.A. 80, pp. 4546–4550.
Chase, T.N., (1997) A gene for Parkinson disease.Arch Neurol 54, pp. 1156–1157.
Chomczynski, P., (1993) A reagent for the single step simultaneous isolation of RNA, DNA and protein from cell and tissue samples.Biotechniques 15, pp. 532–537.
Coleman, T., Ellis, S.W., Martin, J., Lennard, M.S. and Tucker G.T., (1996) l-Methyl-4-phenyl-l,2,3,6-tetrahydropyrid-ine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4 — Implications for susceptibility to Parkinson’s disease.J. Pharmacol. Exp. Ther. 277, pp. 685–690.
Davis, G.C., Williams, A.C., Markey, S.P., Elbert, M.H., Caine, E.D., Reichert, CM. and Kopin I.J., (1979) Chronic Parkinsonism is secondary to intravenous injection of mepredine analogues.Psychiatric Res. 1: pp. 249–254.
Di Monte, D.A., Wu, E.Y., Irwin, I., Dellanney, L.E. and Langston J.W., (1991) Biotransformation of l-methyl-4-phenyl-l,2,3,6-tetrahydro-pyridine in primary cultures of mouse astrocytes.J. Pharmacol. Exp. Ther. 258, pp. 594–600.
Gilham, D.E., Cairns, W., Paine, M.J., Modi, S., Poulsom, R., Roberts, G.C. and Wolf C.R., (1997) Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain byin situ hybridization.Xenobiotica 27, pp. 111–125.
Gonzalez, F.J., Vilbois, F., Hardwick, J.P., McBride, O.W., Nebert, D.W., Gelboin, H.V., Meyer, U.A., (1988): Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.Genomics 2: pp. 174–9.
Gram, T.E., Okine, L.K. and Gram R.A., (1986) The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity, inAnn.Rev. Pharmacol. Toxicol., (George, R, Okun, R and Cho, AK, eds) vol.26, pp. 259–291, Annual Reviews Inc., New York.
Kevil, C.G., Walsh, L., Laroux, S., Kalogeris, T., Grisham, M.B. and Alexander J.S., (1997) An improved, rapid northern protocol.Biochem. Biophys. Res. Commun. 238, pp 277–279.
Komuri, M., (1993) A novel P-450 expressed at the high level in rat brain.Biochem. Biophys. Res. Commun. 196: pp. 721–728.
Laemmli, U.K., and Favre, M., (1973) Maturation of the head of bacteriophage T4, DNA packaging events.J. Mol. Biol. 86, pp. 574–599.
McCann, S.J., Pond, S.M., James, K.M. and Le Couteur D.G., (1997) The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson’s disease: a case-control study and meta-analysis.J. Neurol. Sci.,153, pp. 50–53.
Menegon, A., Board, P.G., Blackburn, A.C., Mellick, G.D. and Le Couteur D.G., (1998) Parkinson’s disease, pesticides and glutathione transferase polymorphisms.Lancet 352, pp. 1344–6.
Mizuno, Y., Mori, H. and Kondo T., (1995) Parkinson’s disease: from etiology to treatment.Intern. Med. 34, pp. 1045–1054.
Ramsay, R.R., Salach, J.I., Dadgar, J. and Singer T.P., (1986) Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic Parkinsonism.Biochem. Biophys. Res. Commun. 135, pp. 259–275.
Ravindranath, V. and Anandatheerthavarada H.K., (1990) Preparation of brain microsomes with cytochrome P-450 activity using calcium aggregation method.Anal. Biochem. 187: pp. 310–313.
Riedl, A.G., Watts, P.M., Jenner, P. and Marsden CD., (1998) P450 enzymes and Parkinson’s disease: the story so far.Mov Disord. 13, pp. 212–220.
Towbin, M., Staehelin, T. and Gordon J., (1979) Electro-phoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications.Proc. Natl. Acad. Sci. USA. 76, pp. 4350–4354.
Smith, C.A., Gough, A.C., Leigh, P.N., Summers, B.A., Harding, A.E., Maraganore, D.M., Sturman, S.G., Schapira, A.H., Williams, A.C., Spurr, N.K. and Wolf C.R., (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’s disease.Lancet 339, pp. 1375–1357.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Upadhya, S.C., Boyd, M.R. & Ravindranath, V. Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: Relevance to Parkinson’s disease. neurotox res 3, 369–380 (2001). https://doi.org/10.1007/BF03033198
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033198